Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2026)
Twist Bioscience (TWST) posted quarterly Income from Continuing Operations of 44021000.0 for Q1 2026, down 11.93% year-over-year from 49985791.48 in Q1 2025, and down 44.3% quarter-over-quarter from 30507000.0 in Q4 2025.
Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Twist Bioscience (TWST) has reported Income from Continuing Operations for 10 consecutive years, with 44021000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 11.93% year-over-year to 44021000.0; the TTM figure through Mar 2026 stood at 81247000.0 (up 57.5% YoY), while the FY2025 annual figure was 77670000.0, up 62.79% from the prior year.
- Income from Continuing Operations eased to 44021000.0 in Q1 2026 per TWST's latest filing, from 30507000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 20381000.0 in Q2 2025 and bottomed at 85571000.0 in Q2 2024.
- Historically, Income from Continuing Operations has averaged 43402000.0 across 5 years, with a median of 44021000.0 in 2026.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 59.99% — and 2025, when it soared 123.82%.
- Twist Bioscience's Income from Continuing Operations stood at 41824000.0 in 2022, then declined by 2.78% to 42988000.0 in 2023, then climbed by 26.5% to 31597000.0 in 2024, then climbed by 3.45% to 30507000.0 in 2025, then slumped by 44.3% to 44021000.0 in 2026.
- Business Quant data shows TWST's Income from Continuing Operations at 44021000.0 in Q1 2026, 30507000.0 in Q4 2025, and 27100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Twist Bioscience | 9.55 Bn | 9.38 Bn | 62.45 Mn | -35.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.05 Mn |
| Mar 31, 2026 | -44.02 Mn |
| Dec 31, 2025 | -30.55 Mn |
| Sep 30, 2025 | -27.10 Mn |
| Jun 30, 2025 | 20.38 Mn |
| Mar 31, 2025 | -39.35 Mn |
| Dec 31, 2024 | -31.60 Mn |
| Sep 30, 2024 | -34.65 Mn |
| Jun 30, 2024 | -85.58 Mn |
| Mar 31, 2024 | -45.49 Mn |
| Dec 31, 2023 | -43.01 Mn |
| Sep 30, 2023 | -46.27 Mn |
| Jun 30, 2023 | -57.40 Mn |
| Mar 31, 2023 | -59.18 Mn |
| Dec 31, 2022 | -41.82 Mn |
| Sep 30, 2022 | -51.12 Mn |
| Jun 30, 2022 | -60.52 Mn |
| Mar 31, 2022 | -60.67 Mn |
| Dec 31, 2021 | -45.56 Mn |
| Sep 30, 2021 | -41.24 Mn |